RPS6KB1 and lip and oral cavity carcinoma: Our results therefore implicate potential links between the various effects of ME to inhibit oral cancer cells, including impaired complex I activity, increased ROS generation, Prx oxidation, activation of AMPK, inhibition of STAT3 and p70S6K phosphorylation, and suppression of HKII.